| scholarly article | Q13442814 |
| P2093 | author name string | Zhang H | |
| Lim HK | |||
| Ball SE | |||
| Cornelius G | |||
| Dierks EA | |||
| Stams KR | |||
| P433 | issue | 1 | |
| P921 | main subject | liquid chromatography-tandem mass spectrometry | Q117788892 |
| P304 | page(s) | 23-29 | |
| P577 | publication date | 2001-01-01 | |
| P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
| P1476 | title | A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry | |
| P478 | volume | 29 |
| Q36872144 | An improved substrate cocktail for assessing direct inhibition and time-dependent inhibition of multiple cytochrome P450s |
| Q49472565 | An in-vitro cocktail assay for assessing compound-mediated inhibition of six major cytochrome P450 enzymes |
| Q89778130 | Antibacterial activity of novel dual bacterial DNA type II topoisomerase inhibitors |
| Q37845170 | Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity |
| Q37399435 | Cranberry juice suppressed the diclofenac metabolism by human liver microsomes, but not in healthy human subjects |
| Q57064980 | Current High-Throughput Approaches of Screening Modulatory Effects of Xenobiotics on Cytochrome P450 (CYP) Enzymes |
| Q89461517 | Cyp1 Inhibition Prevents Doxorubicin-Induced Cardiomyopathy in a Zebrafish Heart-Failure Model |
| Q33467340 | Development of a fluorescence-based, ultra high-throughput screening platform for nanoliter-scale cytochrome p450 microarrays |
| Q35882103 | Effect of a New Prokinetic Agent DA-9701 Formulated with Corydalis Tuber and Pharbitidis Semen on Cytochrome P450 and UDP-Glucuronosyltransferase Enzyme Activities in Human Liver Microsomes |
| Q84778574 | Effects of furanocoumarins from apiaceous vegetables on the catalytic activity of recombinant human cytochrome P-450 1A2 |
| Q35119637 | Evaluation of CYP450 inhibitory effects and steady-state pharmacokinetics of genistein in combination with cholecalciferol and citrated zinc bisglycinate in postmenopausal women |
| Q89910223 | Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models |
| Q21144517 | Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness |
| Q80214441 | Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese |
| Q36186126 | High-Throughput Cytochrome P450 Cocktail Inhibition Assay for Assessing Drug-Drug and Drug-Botanical Interactions. |
| Q36982824 | High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain |
| Q41534845 | In Vitro Evaluation of Reversible and Time-Dependent Inhibitory Effects of Kalanchoe crenata on CYP2C19 and CYP3A4 Activities |
| Q37237438 | In vitro evaluation of reversible and irreversible cytochrome P450 inhibition: current status on methodologies and their utility for predicting drug-drug interactions |
| Q38997725 | In vitro inhibitory effects of scutellarin on six human/rat cytochrome P450 enzymes and P-glycoprotein. |
| Q34292559 | In vitro metabolism and metabolic effects of ajulemic acid, a synthetic cannabinoid agonist |
| Q44684320 | In vitro permeability of poorly aqueous soluble compounds using different solubilizers in the PAMPA assay with liquid chromatography/mass spectrometry detection |
| Q36323058 | Microsome biocolloids for rapid drug metabolism and inhibition assessment by LC-MS |
| Q36718265 | Models of drug-induced liver injury for evaluation of phytotherapeutics and other natural products. |
| Q91720676 | Probe Cocktail to Assess Transporter Function in Sandwich-Cultured Human Hepatocytes |
| Q35049310 | Strategies and molecular probes to investigate the role of cytochrome P450 in drug metabolism: focus on in vitro studies. |
| Q36749461 | The evolving role of drug metabolism in drug discovery and development |
| Q42326752 | The paraoxonase-1 pathway is not a major bioactivation pathway of clopidogrel in vitro |
| Q90599845 | Understanding the relevance of herb-drug interaction studies with special focus on interplays: a prerequisite for integrative medicine |
Search more.